Orchestra BioMed Holdings, Inc. (OBIO) closed the last trading session at $6.93, gaining 35.9% over the past four weeks, but there could be plenty of upside left in the stock if short-term price targets set by Wall Street analysts are any guide. The mean price target of $16.33 indicates a 135.6% upside potential. The average comprises three short-term price targets ranging from a low of $14 to a high of $20, with a standard deviation of $3.21. While the lowest estimate indicates an increase of 102% from the ...